Skip to content

Alkermes ALKS Price / sales

Price / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.6×-0.1×
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
2.6×+0.8×
AbbVie logo
AbbVieABBV
6.1×-0.3×
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
12.2×-1.0×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
11.7×+5.0×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.3×-0.3×

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Calculated from Alkermes’s reported figures.

Based on the most recent quarter.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's price / sales?
Alkermes (ALKS) reported price / sales of 3.8× in Q1 2026.
How has Alkermes's price / sales changed year-over-year?
Alkermes's price / sales increased by 6.3% year-over-year, from 3.5× to 3.8×.
What is the long-term trend for Alkermes's price / sales?
Over 5 years (2020 to 2025), Alkermes's price / sales has grown at a 0.2% compound annual growth rate (CAGR), from 3.1× to 3.1×.
What does price / sales mean?
How many dollars investors pay for each dollar of the company's annual sales.
How do you interpret price / sales?
Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
How does price / sales compare across companies?
Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.